Maxwell Biosciences is working on the biomimetic cure against SARS COV-2 virus. The CLAROMERTM brand generates a library of oligomeric structures
Maxwell Biosciences is working on the biomimetic cure against SARS COV-2 virus. The CLAROMERTM brand generates a library of oligomeric structures